PedTrak
Medical device

Nurses founded PedTrak to help clinicians track a pulse in an arm or leg. Our managing partner brought product and commercialization experience to the prototype team.
We help researchers and founders find a first market for a discovery and decide whether to license it or build a company.
Discuss your project
Medical device

Nurses founded PedTrak to help clinicians track a pulse in an arm or leg. Our managing partner brought product and commercialization experience to the prototype team.
Nuclear medicine

These iodide capsules come from research at Brazil’s Institute of Nuclear Engineering. Our managing partner leads commercialization of Radion’s radiopharmaceutical production technology.
Industrial software

Limis turns an operator’s field readings into a plant record. Our managing partner helped the team scope how manufacturers could test the software on site.
Care documentation

A nurse could dictate a bedside observation through smart glasses and review the chart entry. Our managing partner co-founded and led LifeLensAR before its acquisition in 2025.
Lab robotics, advanced materials and tools for scientific discovery.
Medical isotopes and the systems that produce and handle them safely.
Safer workplaces and wider access to care, with a way to measure who benefits.
Doctors use technetium-99m for diagnostic imaging and lutetium-177 for targeted cancer therapy.
Each block is one isotope. Taller blocks have more steps along the chart’s modeled decay path.
Each sphere represents one proton or neutron. The smaller nuclei contain fewer particles.
Actinium-225
89 protons, 136 neutrons. Targeted alpha therapy.
Most projects start with a researcher or founder asking who could put a discovery to use.
You have validated science and no clear route to market. We help you choose a license, a spinout or a partnership, then build it with you.
You have validated science and no clear route to market. We help you choose a license, a spinout or a partnership, then build it with you.
What we do for researchersYou are building on hard science and need commercial proof, partners and capital. We work beside you from formation through early financing.
What we do for foundersFamily offices and funds that want a technically grounded view of deep-tech and nuclear work. Conversations are private.
How VentureIP worksBring a research, deployment or market-access question that someone in our network can help you test.
How the network worksThe first decision is whether to form a company, license the technology or develop it with a partner.
Step 1
You leave withA technical and IP readout you can act on.
Step 2
You leave withA chosen route to market and the reasons for it.
Step 3
You leave withA company, a license or a partnership with a plan behind it.
Step 4
You leave withIntroductions made when the case is ready, not before.

Research
University researchers, research institutes and technical experts help choose the experiment that would settle an open question.
See how VentureIP reviews evidenceCommercialization
Operators, corporate partners and technology transfer teams help define a first use and what a pilot would need to prove.
See the Xelios pilot planInvestment
Partner funds, family offices and strategic investors weigh the cost of the next milestone and the evidence behind it.
How we work with investorsManaging Partner
Seattle and São Paulo
Thesis, commercialization strategy, nuclear and deep-tech partnerships
General Partner and Co-Founder
United Kingdom and Europe
Founder support, ecosystem partnerships, social impact
General Partner and Co-Founder
Tell us what you’ve tested and where you could use a partner.